A research study with the aim of assessing  the efficacy and safety of subcallosal cingulate Deep Brain Stimulation in patients with Treatment-Resistant Depression with either major depressive disorder (MDD) or bipolar II disorder (BP).

The Balanced Mind Foundation is committed to providing parents with current information about treatments and resources that have a proven track record of success.  To learn more we sat down individually with three leading clinicians who are pioneering the charge to include your entire family in therapy.  While the approaches differ in some important respects, they all share the common goal of working with kids with bipolar disorder in an inclusive family context.  Learning about these approaches to therapy will provide parents with the information they need to seek the treatment approach that best suites the needs of their child and their family.

The Balanced Mind Foundation is committed to providing parents with current information about treatments and resources that have a proven track record of success.  To learn more we sat down individually with three leading clinicians who are pioneering the charge to include your entire family in therapy.  While the approaches differ in some important respects, they all share the common goal of working with kids with bipolar disorder in an inclusive family context.  Learning about these approaches to therapy will provide parents with the information they need to seek the treatment approach that best suites the needs of their child and their family.

The Balanced Mind Foundation 2010 Form 990

The Balanced Mind Foundation's partner, Bring Change 2 Mind, a non-profit organization working to eliminate the stigma of mental illness, has exciting news to share with you.

"Mommy, Am I Really Bipolar?", Letter to the Editor, Newsweek, June 29, 2011, by Susan Resko, The Balanced Mind Foundation Executive Director

June 29, 2011

THE OPPORTUNITY: Volunteering with The Balanced Mind Foundation's Helpline is a great way to make a difference for families impacted by mood disorders.  At the same time you can sharpen existing skills, learn new ones and expand your knowledge about mood disorders, treatments and interventions. Our mission is to help parents find the information, resources and support that they need to make the best decisions for their child’s care and treatment.

The FDA (Food & Drug Administration) approved use of Abilify for maintenance of bipolar disorder in 2005.  But a recent article published in the open access journal PLoS Medicine (Tsai, et al) looks critically at the science behind the decision to approve Abilify.  The results were one blind, randomized trial sponsored by the pharmaceutical company that makes Abilify, Bristol Meyers Squibb.  Article exposes flaws in trial to show we currently do not have enough evidence to know whether or not Abilify is effective in the maintenance of bipolar disorder.  Article also features step-by-step advice for people currently taking Abilify.